Home/Filings/4/0000318154-25-000075
4//SEC Filing

Busch Matthew C. 4

Accession 0000318154-25-000075

CIK 0000318154other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 7:54 PM ET

Size

6.8 KB

Accession

0000318154-25-000075

Insider Transaction Report

Form 4
Period: 2025-11-05
Busch Matthew C.
VP, Finance & CAO
Transactions
  • Tax Payment

    Common Stock

    2025-11-05$296.70/sh202$59,9334,414 total
Footnotes (1)
  • [F1]These shares include 51 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001987926

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 7:54 PM ET
Size
6.8 KB